In this eye-opening interview, neuroscientist Dr. Dayan Goodenowe shares his groundbreaking research on the critical role of a little-known molecule called plasmalogens in preventing and even reversing Alzheimer’s, dementia, and other neurodegenerative diseases. Dr. Goodenowe explains how his advanced metabolic profiling technology allowed him to identify plasmalogens as a predictive biomarker for cognitive decline, decades before symptoms appear. He reveals how plasmalogen deficiencies are a primary driver behind the development of Alzheimer’s, Parkinson’s, multiple sclerosis, and more. Dive into the science behind how plasmalogens maintain the integrity of brain cell membranes, facilitate neurotransmitter release, and support myelination – the key to healthy brain function. Discover the shocking truth about the connection between plasmalogens, ApoE4 genetic risk, and Alzheimer’s onset. Prepare to be amazed as Dr. Goodenowe shares case studies of patients reversing cognitive decline, restoring vision, and even rebuilding brain tissue through targeted plasmalogen restoration. Learn about the plasmalogen precursors that may hold the key to unlocking your body’s fountain of youth. This interview is a must-watch for anyone concerned about brain health, longevity, and the future of neurodegenerative disease treatment. Get ready to rethink everything you thought you knew about aging and unlock the secrets to lifelong vitality.
